98 related articles for article (PubMed ID: 35698239)
1. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
2. Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.
Tunkel AE; Youner ER; Barseghyan H; Fu Y; Bhattacharya S; Bornhorst M; Monfared AS
Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38527168
[TBL] [Abstract][Full Text] [Related]
3. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1: Clinical characteristics and mutation spectrum in a North Indian cohort.
Srivastava P; Gupta S; Bamba C; Daniel R; Kaur P; Kaur A; Panigrahi I; Mandal K
Heliyon; 2024 Jan; 10(1):e23685. PubMed ID: 38226287
[TBL] [Abstract][Full Text] [Related]
5. Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis.
Tamura R; Yo M; Toda M
Neurol Med Chir (Tokyo); 2024 Jun; ():. PubMed ID: 38897938
[TBL] [Abstract][Full Text] [Related]
6.
Forde C; Smith MJ; Burghel GJ; Bowers N; Roberts N; Lavin T; Halliday J; King AT; Rutherford S; Pathmanaban ON; Lloyd S; Freeman S; Halliday D; Parry A; Axon P; Buttimore J; Afridi S; Obholzer R; Laitt R; Thomas O; Stivaros SM; Vassallo G; Evans DG
J Med Genet; 2024 Jun; ():. PubMed ID: 38925914
[TBL] [Abstract][Full Text] [Related]
7. Fluorescein-guided removal of peripheral nerve sheath tumors: a preliminary analysis of 20 cases.
Vetrano IG; Acerbi F; Falco J; Devigili G; Rinaldo S; Messina G; Prada F; D'Ammando A; Nazzi V
J Neurosurg; 2019 Dec; 134(1):260-269. PubMed ID: 31812148
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.
Banerjee J; Friedman JM; Klesse LJ; Yohay KH; Jordan JT; Plotkin SR; Allaway RJ; Blakeley JO
Genet Med; 2023 Feb; 25(2):100324. PubMed ID: 36565307
[TBL] [Abstract][Full Text] [Related]
9. Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of
Reinhold V; Saarinen A; Suominen E; Syrjänen S; Kankuri-Tammilehto M
Orthop Res Rev; 2023; 15():183-189. PubMed ID: 37791039
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of High Resolution Ultrasound Evaluation of the "Split Fat Sign" in Peripheral Nerve Sheath Tumors.
Deka JB; Shah R; Jiménez M; Bhatnagar N; Bravo-Sánchez A; Piñas-Bonilla I; Abián-Vicén J; Jiménez F
Healthcare (Basel); 2023 Dec; 11(24):. PubMed ID: 38132037
[TBL] [Abstract][Full Text] [Related]
11. Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.
Vidal-Millan S; Zatarain-Barrón ZL; Daza-Galicia K; Shveid Gerson D; Pichardo-Rojas PS; Salazar-Pigeon A; Wegman-Ostrosky T
Front Oncol; 2023; 13():1291286. PubMed ID: 38260834
[TBL] [Abstract][Full Text] [Related]
12. Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1.
Gregório C; Rosset C; Alves LDS; Netto CBO; Machado SMDS; Bersch VP; Osvaldt AB; Ashton-Prolla P
Front Genet; 2020; 11():395. PubMed ID: 32425982
[TBL] [Abstract][Full Text] [Related]
13. A genotype-first approach identifies high incidence of
Safonov A; Nomakuchi TT; Chao E; Horton C; Dolinsky JS; Yussuf A; Richardson M; Speare V; Li S; Bogus ZC; Bonanni M; Raper A; Kallish S; Ritchie MD; ; ; Nathanson KL; Drivas TG
medRxiv; 2023 Aug; ():. PubMed ID: 37609227
[TBL] [Abstract][Full Text] [Related]
14. A case of infantile spasms with three possibly pathogenic de novo missense variants in NF1 and GABBR1.
Watanabe K; Kubota K; Nakashima M; Saitsu H
Hum Genome Var; 2023 Nov; 10(1):30. PubMed ID: 37993422
[TBL] [Abstract][Full Text] [Related]
15. Novel Pathogenic Missense
Arshad F; Prasad A; Somaraj A; Udupi GA; Ramakrishnan S; Alladi S
Dement Neurocogn Disord; 2024 Jan; 23(1):71-73. PubMed ID: 38362057
[No Abstract] [Full Text] [Related]
16.
Li X; Hu X; Wang P; Cai J
Front Med (Lausanne); 2024; 11():1346647. PubMed ID: 38576707
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore.
Loh J; Ong PY; Goh DLM; Puhaindran ME; Vellayappan BA; Ow SGW; Chan G; Lee SC
Hered Cancer Clin Pract; 2022 Jun; 20(1):23. PubMed ID: 35698239
[TBL] [Abstract][Full Text] [Related]
18. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
Perez-Becerril C; Evans DG; Smith MJ
Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]